Murathan Uyar

Educational Background2002-2006 Medical Faculty of Baskent University (Ankara) - Minor Training of Nephrology2001-2002 Medical Faculty of Baskent University (Ankara) - Internal Medicine Specialist1997-2001Internal Medicine Speciality Training in Ankara Numune Training and Research Hospital1990-1996 Undergraduate Study in the Medical Faculty of Hacettepe University Medical Faculty (in English language) (Ankara)1987-1990 Trabson Anatolian High School (High School Education)1983-1987 Samsun Anatolian High School (Seondary Education)1978-1983 Hurriyet Primary School (Ankara) (Primary Education)Business Experiences2006-January 2009 Nephrology Specialist in Avukat Cengiz Gokcek State Hospital (Gaziantep) as a civil service obligant. Responsible doctor for Nephrology and Hemodialysis March 2009-June 2009 Acıbadem Maslak Hospital (Istanbul Nephrology Specialist June 2009-...... Nephrology Specialist (Renal Transplantation) in Private Gaziosmanpasa Hospital (Istanbul)Practical Training: 1994 - Gregorio Maranon Hospital (Madrid/Spain) 4-weeks Practical Training of Internal Diseases; 1996 – Gulveren Family Planning Clinic (Ankara) 6 weeks Training of Family Planning certified by the Ministry of HealthForeign LanguagesEnglishPlace and Date of Birth03.11.1972Scientific PublicationsAdherence, depression and quality of life in patients on a renal transplantation waiting list. Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M. Transpl Int. 2007 Aug;20(8):682-7. Epub 2007 May 29.Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Bozbas H, Atar I, Yildirir A, Ozgul A, Uyar M, Ozdemir N, Muderrisoglu H, Ozin B. Ren Fail. 2007;29(3):331-9.Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids. Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M. Transplant Proc. 2007 Jan-Feb;39(1):135-7.Effects of ACE gene polymorphism on vitamin D therapy according to parathyroid hormone level in patients on hemodialysis. Kulah E, Sezer S, Uyar M, Arat Z, Ozdemir FN. Adv Ther. 2006 Sep-Oct;23(5):778-86.1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients. Uyar M, Sezer S, Arat Z, Elsurer R, Ozdemir FN, Haberal M. Transplant Proc. 2006 Sep;38(7):2069-73.Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Sezer S, Bilgic A, Uyar M, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2006 Mar;38(2):529-32.Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Sezer S, Uyar M, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2005 Sep;37(7):3109-11.Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal. Sezer S, Ozdemir FN, Elsurer R, Uyar M, Arat Z, Haberal M. Transplant Proc. 2005 Sep;37(7):2994-7.Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal. Sezer S, Ozdemir FN, Elsurer R, Uyar M, Arat Z, Haberal M. Transplant Proc. 2005 Sep;37(7):2994-7.Pulmonary function in uremic patients on long-term hemodialysis. Karacan O, Tutal E, Uyar M, EyŸboÛlu FO, Sezer S, Ozdemir FN. Ren Fail. 2004 May;26(3):273-8.Predictors of hematopoietic response after renal transplantation. Arat Z, Sezer S, Ozdemir FN, Uyar M, Turan M, Haberal M. Transplant Proc. 2003 Nov; 35(7): 2716-7